Pathology of intraductal papillary mucinous neoplasms.

Langenbecks Arch Surg

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD, 21212, USA.

Published: December 2021

Background: Intraductal papillary mucinous neoplasms (IPMNs) represent a unique opportunity to treat and prevent a curable neoplasm before it has the chance to progress to incurable cancer. This prospect, however, has to be balanced with the real risk of over treating patients with lesions that would, in fact, never progress during the life of the patient.

Purpose: Informed clinical decisions in the treatment of IPMNs are first and foremost based on a deep understanding of the pathology of these lesions.

Conclusions: Here we review the pathology of IPMNs, with an emphasis on the clinical relevance of the important features that characterize these lesions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281515PMC
http://dx.doi.org/10.1007/s00423-021-02201-0DOI Listing

Publication Analysis

Top Keywords

intraductal papillary
8
papillary mucinous
8
mucinous neoplasms
8
pathology intraductal
4
neoplasms background
4
background intraductal
4
neoplasms ipmns
4
ipmns represent
4
represent unique
4
unique opportunity
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!